Stories about research and scientific development at Mount Sinai
Researchers Identify Potential Ebola-Fighting Drugs
Researchers at the Icahn School of Medicine at Mount Sinai have identified 53 drugs approved for use in treating depression, cancer, heart disease, and other illnesses that may also be effective in fighting the Ebola virus. The findings appeared online in the December...
A New Era for Bone Marrow Transplantation
Seminal research led by James Ferrara, MD, DSc, Ward-Coleman Chair in Cancer Medicine, has produced a promising approach to treating patients with graft-versus-host disease (GVHD)—a sometimes fatal complication of bone marrow transplantation in which the donor’s...
Attention Statin Patients: Are You Experiencing Muscle Aches, Weakness, Decreased Exercise Capacity, “Brain Fog”, Impaired Clarity, or Memory Loss?
If you are experiencing any of these symptoms, you may have statin intolerance. What are statins? Statins are a class of cholesterol lowering medication therapies that have been extensively evaluated in controlled clinical trial studies. These medications have been...
Top Honors for Groundbreaking Researchers
For the first time in its 47-year history, the Crohn’s & Colitis Foundation of America has awarded all three of its 2014 annual scientific achievement awards to research and academic luminaries at the Mount Sinai Health System. “It seems quite fitting that they...
Studying New Stem Cell Therapies for Vision Recovery
The National Eye Institute (NEI), a division of the National Institutes of Health, has awarded researchers at Icahn School of Medicine at Mount Sinai a five-year grant to support an effort to recreate a patient’s ocular stem cells and restore vision in those blinded...
SinaInnovations Spotlights a New Era of Discovery
“We have learned that the impossible is possible, and advances are being made that we could not have imagined just a few years ago,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs,...
Department of Pharmacology and Systems Therapeutics Awarded More Than $31 Million in NIH Grants
Researchers at the Icahn School of Medicine at Mount Sinai have received more than $31 million from the National Institutes of Health (NIH) to create three new centers that will study how drugs interact with human cells to increase their effectiveness and decrease...
Potential New Drug and Clinical Trial: Sarcoidosis Goes “Modern” with Crowdsourcing
Developing new drugs for the treatment of sarcoidosis isn’t easy. First, the cause of sarcoidosis is unknown. Second, prednisone, a remarkably effective medication for the treatment of sarcoidosis, limited only by its adverse side effect profile, is tough to beat....
Cardiovascular Risk Factors May Lead to Early Brain Changes
Abnormalities in the structure and function of the brain can appear in people who are overweight, smoke, have diabetes, hypertension, elevated lipids, or metabolic syndrome before the other consequences of vascular risk factors—such as a heart attack or stroke—appear,...